Cost-effectiveness of alternative first- and second-line treatments for benign prostatic hyperplasia in Singapore
10.1080/13696998.2023.2266958
Saved in:
Main Authors: | Junxing Chay, Joshua Y. M. Tung, Rebecca Jade Su, Edwin J. Aslim, Callix Wong, Georgia Swan, Wei Jin Chua, Henry S. S. Ho, E Finkelstein |
---|---|
Other Authors: | DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL) |
Format: | Article |
Published: |
Taylor & Francis
2024
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/246755 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A cost-effectiveness analysis of pharmacotherapy versus prostatic urethral lift as initial therapy for patients with moderate benign prostatic hyperplasia
by: Joshua Tung, et al.
Published: (2023) -
Understanding the role of estrogen in the development of benign prostatic hyperplasia
by: A. Ajayi, et al.
Published: (2019) -
Alternative therapy for benign prostatic hypertrophy.
by: Tung, K.H.
Published: (2011) -
Minimally invasive surgery for benign prostatic hyperplasia--a review.
by: Kour, N.W.
Published: (2011) -
Minimally invasive surgery for benign prostatic hyperplasia--a review.
by: Kour, N.W.
Published: (2016)